We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finalizes Orphan Drug Rules, Updates Misinterpreted Terms
FDA Finalizes Orphan Drug Rules, Updates Misinterpreted Terms
June 14, 2013
The FDA has finalized changes to orphan drug regulations, clarifying confusion around orphan drug designation and the terms that have hung up sponsors of rare-disease treatments.